Burgy, O.* ; Mayr, C.H.* ; Schenesse, D.* ; Fousekis Papakonstantinou, E.* ; Ballester, B. ; Sengupta, A. ; She, Y.* ; Hu, Q.* ; Melo-Narváez, M.C ; Jain, E. ; Pestoni, J. ; Mozurak, M.* ; Estrada-Bernal, A.* ; Onwuka, U.* ; Coughlan, C.* ; Parimon, T.* ; Chen, P.* ; Heimerl, T.* ; Bange, G.* ; Schmeck, B.T.* ; Lindner, M. ; Hilgendorff, A. ; Ruppert, C.* ; Guenther, A.* ; Mann, M.* ; Yildirim, A.Ö. ; Eickelberg, O.* ; Jung, A.L.* ; Schiller, H. ; Lehmann, M. ; Burgstaller, G. ; Königshoff, M.*
Fibroblast-derived extracellular vesicles contain SFRP1 and mediate pulmonary fibrosis.
JCI insight 9:e168889 (2024)
Idiopathic pulmonary fibrosis (IPF) is a lethal chronic lung disease characterized by aberrant intercellular communication, extracellular matrix deposition, and destruction of functional lung tissue. While extracellular vesicles (EVs) accumulate in the IPF lung, their cargo and biological effects remain unclear. We interrogated the proteome of EV and non-EV fractions during pulmonary fibrosis and characterized their contribution to fibrosis. EVs accumulated 14 days after bleomycin challenge, correlating with decreased lung function and initiated fibrogenesis in healthy precision-cut lung slices. Label-free proteomics of bronchoalveolar lavage fluid EVs (BALF-EVs) collected from mice challenged with bleomycin or control identified 107 proteins enriched in fibrotic vesicles. Multiomic analysis revealed fibroblasts as a major cellular source of BALF-EV cargo, which was enriched in secreted frizzled related protein 1 (SFRP1). Sfrp1 deficiency inhibited the activity of fibroblast-derived EVs to potentiate lung fibrosis in vivo. SFRP1 led to increased transitional cell markers, such as keratin 8, and WNT/β-catenin signaling in primary alveolar type 2 cells. SFRP1 was expressed within the IPF lung and localized at the surface of EVs from patient-derived fibroblasts and BALF. Our work reveals altered EV protein cargo in fibrotic EVs promoting fibrogenesis and identifies fibroblast-derived vesicular SFRP1 as a fibrotic mediator and potential therapeutic target for IPF.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Cell Biology ; Fibrosis ; Molecular Biology ; Pulmonology; Exosomes; Pathogenesis; Progenitors; Mechanisms; Responses; Release
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2024
Prepublished im Jahr
0
HGF-Berichtsjahr
2024
ISSN (print) / ISBN
2379-3708
e-ISSN
2379-3708
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 9,
Heft: 18,
Seiten: ,
Artikelnummer: e168889
Supplement: ,
Reihe
Verlag
Clarivate
Verlagsort
Ann Arbor, Michigan
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30202 - Environmental Health
80000 - German Center for Lung Research
Forschungsfeld(er)
Lung Research
PSP-Element(e)
G-501600-014
G-501600-005
G-505000-001
G-501600-001
G-501800-820
G-501600-003
G-552100-001
G-505000-007
G-501693-001
G-501800-810
Förderungen
Technology Enhancing Cognition and Health Geriatric Research Education and Clinical Center at the VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA
European Molecular Biology Organization (ERS/EMBO Joint Research Fellowship)
ERS
European Union
French National Research Agency (ANR)
NIH
DZL
Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
Von Behring Roentgen Foundation
Helmholtz Association
European Respiratory Society
Copyright
Erfassungsdatum
2024-10-29